Eupraxia Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver
EPRX chart
What traders are saying about $EPRX
Latest postsEupraxia Pharmaceuticals Inc. news
- Eupraxia Pharmaceuticals Inc : RBC Initiates
Moomoo ·
- RBC Capital initiates coverage of Eupraxia Pharmaceuticals at Outperform, sets price target at $14
TradingView ·
- RBC Capital Mkts initiated coverage on Eupraxia Pharmaceuticals with a new price target
Quantisnow ·
- RBC Capital initiates Eupraxia Pharmaceuticals stock with outperform rating
Investing.com ·
- William Blair Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating
Moomoo ·
- Eupraxia Pharmaceuticals Inc. (EPRX.TO) Seasonal returns chart
Yahoo Finance Singapore ·
- Eupraxia Pharmaceuticals Inc. [TSX:EPRX]: What Is Moving the Stock and What Comes Next?
kalkine.ca ·
- EUPRAXIA PHARMACEUTICALS INC (EPRX.NE) valuation measures and financial statistics
Yahoo Finance UK ·
- Eupraxia Pharmaceuticals Inc. Shares Advance 2.99% as Investors Reassess Growth Potential
kalkine.ca ·
- Eupraxia Pharmaceuticals Inc. (EPRX) Seasonal returns chart
Yahoo Finance UK ·
- Eupraxia Pharmaceuticals Inc. (TSX:EPRX): What Could Drive the Next Market Move as Investors Assess Healthcare Prospects
kalkine.ca ·
- Eupraxia Pharmaceuticals to Participate at Upcoming Conferences and Host a Virtual Analyst Day
Yahoo Finance ·
Eupraxia Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| Net income | -$38.6M | -$25.5M | -$28.2M | -$18.5M |
| Diluted EPS | $-1.03 | $-0.76 | $-1.17 | $-0.96 |
| Total assets (year end) | $86.2M | $34.9M | $20.3M | $19.1M |
| Cash and equivalents (year end) | $80.6M | $33.1M | $19.3M | $18.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Eupraxia Pharmaceuticals Inc.
- Ticker
- EPRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1581178
Frequently asked questions
What exchange is Eupraxia Pharmaceuticals Inc. listed on?
Eupraxia Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol EPRX.
What industry is Eupraxia Pharmaceuticals Inc. in?
Eupraxia Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Eupraxia Pharmaceuticals Inc. headquartered?
Eupraxia Pharmaceuticals Inc.'s business address on file with the SEC is in Vancouver.
When does Eupraxia Pharmaceuticals Inc.'s fiscal year end?
Eupraxia Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Eupraxia Pharmaceuticals Inc. report?
Eupraxia Pharmaceuticals Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.